Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Provenge extends prostate cancer survival by about 4 months.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Testosterone may influence COVID-19 severity and outcomes.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.